Drugs / Lactobacillus LB
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06151392 Comparator | Jul 2023 → Dec 2025 overdue | infectious disorder of the nervous system | Ain Shams University | Recruiting | No outcome recorded |
| Phase 4 | NCT04053790 Comparator | Jan 2019 → Jan 2023 | irritable bowel syndrome | Hospital General de Mexico | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus LB | “Lacteol fort ® Sachets manufactured by Rameda contains Lactobacillus LB corresponding to lactobacillus delbruekii and lactobacillus fermentum 10 billion units per sachet.” NCT06151392 ↗ |